Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"Nice Insight offers a unique perspective by tracking critical data relating
to the pharmaceutical CRO/CMO marketplace. The data they garner, as well as
their overall approach, puts them in a leading position for market
research."
Jeff Reinke editorial director, Pharmaceutical Processing & Manufacturing.net  
Pharma Chem Outsourcing 2013
September 16-18 Long Branch, NJ |
Aragen Bioscience, Inc. Bertin Pharma Charles River Laboratories International Inc. Covance Inc. Huntingdon Life Sciences MPI Research, Inc. PharmaNet/i3 Pyxant Labs, Inc. Ricerca Biosciences, LLC Toxikon Corporation
Biopharmaceutical Research, Inc. is a specialized analytical, bioanalytical and DM/PK contract research organization. The company serves pharmaceutical and biotechnology companies in discovery, preclinical and clinical programs supporting IND and NDA-enabling studies. It performs quantitative assays on small molecule drugs, metabolites and chemical biomarkers supporting phase I to IV clinical PK samples and DM/PK preclinical samples. Bioanalytical assay experience includes immunochemical ELISA and cell-based assays of small molecule chemical biomarkers and large molecules. The company is also experienced in analytical chemistry and USP monograph assays.
http://
Regions
Stock Symbol Private Filter of 's services per Nice Insight Categories
Contact 
|
|
|
